PDCD1 and age-related macular degeneration: Neuroinflammation and dysregulation of neuroimmune processes are prominent features in various retinal degenerative disorders, including AMD.[20] ICPs have emerged as crucial regulators of inflammation and immune responses, exhibiting significant therapeutic potential in diverse fields, such as oncology[76] and inflammatory disorders.[77] Among these, the PD‐1/PD‐L1 axis stands out as a pivotal molecular component.[38] This study investigated the role and possible mechanisms of PD‐L1 in the laser‐induced CNV model.